COMPASS PATHWAYS PLC (CMPS)

Company Profile

Compass Pathways Plc is an investment holding company. The company is headquartered in Altrincham, Cheshire and currently employs 186 full-time employees. The company went IPO on 2020-09-18. The firm is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. The company commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. The company also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Company Info

COMPASS PATHWAYS PLC

3Rd Floor, 1 Ashley Road

Altrincham CHESHIRE WA14 2DT

P: 17166766461

CEO: George Goldsmith

Employees: 186

Website: https://compasspathways.com/